Pain Therapeutics Logo

Email this page: News Release

Pain Therapeutics Announces FDA Has Cleared an Investigational New Drug (IND) Application for PTI-125


Separate multiple addresses with commas. Maximum 200 characters.

These email addresses will be used to email the page on your behalf and will not be used by Pain Therapeutics for any marketing purposes.


This helps Pain Therapeutics prevent automated submissions.